- 2020
-
Press releases - 27.11.2020
A new cerebral canalopathy associating intellectual disability and abnormal movements
Dysfunctions of ion channels – or channelopathies – in the brain are today associated with more than 30 neurological diseases such as epilepsy or cerebellar ataxias. A study conducted at the Brain Institute (Sorbonne University / Inserm / AP-HP / CNRS) identified a new cerebral channelopathy originating from dominant mutations in the KCNN2 gene, encoding the SK2 ion channel.
-
Press releases - 26.10.2020
Food Emulsifiers Increase Pathogenicity of Certain Bacteria and Risk of Intestinal Inflammation
Diet is believed to play a role in triggering intestinal inflammation that can lead to the development of certain conditions, such as Crohn’s disease. Researchers from Inserm, CNRS and Université de Paris have shown that the emulsifiers present in many processed foods could have a harmful impact on specific bacteria in the gut microbiota, leading to chronic inflammation.
-
Press releases - 19.10.2020
An Immune “Signature” to Identify Diabetic Patients at Risk of Developing Severe Covid-19
Type 2 diabetes is a risk factor for the development of a severe form of Covid-19. Identifying the immune- and inflammatory markers associated with these severe forms of the disease in this patient population would enable earlier and more appropriate care.
-
Press releases - 16.10.2020
A New Therapeutic Target for Type 2 Diabetes Discovered Thanks to a Rare Disease
A new therapeutic target for type 2 diabetes has recently been identified by researchers from Inserm and Université de Strasbourg, in collaboration with several European hospitals.
-
Press releases - 08.10.2020
Fibromyalgia, Knowledge Overview and Recommendations: An Inserm Collective Expert Review
Inserm was tasked by France’s Health Directorate with conducting a Collective Expert Review in order to take stock of the scientific knowledge on fibromyalgia in adults, and also to explore the potential existence of a similar syndrome in children and adolescents. The objective was also to recommend measures and establish research priorities in order to better understand fibromyalgia and improve patient care.
-
Press releases - 07.10.2020
The Placenta Could Retain a Memory of Tobacco Exposure Prior to Pregnancy
A study is showing for the first time that tobacco consumption, even when stopped before pregnancy, can have an impact on the placenta. Smoking not just during but also before pregnancy leads to epigenetic modifications (DNA methylation) which could have consequences on its course.
-
Press releases - 05.10.2020
Nobel Prize 2020
The 2019 Nobel Prize was awarded on Monday, October 7
-
What's on? - 05.10.2020
Nobel Prize 2020
Only available in french
-
Press releases - 01.10.2020
COVID-19 Vaccines: 25,000 Volunteers Needed for Large-Scale Clinical Trials in France – Registration Now Open
Today, COVIREIVAC opens the registration process for volunteers to participate in the first large-scale clinical trials in France.
-
Press releases - 29.09.2020
New Whooping Cough Vaccine In Development
A research team from Inserm, Lille University, Lille University Hospital, CNRS, and the Institut Pasteur of Lille, as part of the Lille Immunity and Infection Center, is developing a new vaccine against whooping cough. En utilisant la bactérie entière mais génétiquement modifiée pour supprimer sa toxicité, les chercheurs espèrent pallier les défauts d’efficacité du vaccin actuel en induisant une réponse immunitaire durable et en bloquant la transmission bactérienne entre individus.